angiotensin ii has been researched along with alarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, H; Li, J; Li, Y; Mei, Y; Wang, W; Zhang, R; Zhou, H | 1 |
| Dong, S; Li, Y; Liu, Y; Shen, T; Wang, X; Xu, X; Zhou, L | 1 |
2 other study(ies) available for angiotensin ii and alarin
| Article | Year |
|---|---|
Alarin alleviated cardiac fibrosis via attenuating oxidative stress in heart failure rats.
Topics: Angiotensin II; Animals; Fibrosis; Galanin-Like Peptide; Heart Failure; Male; Malondialdehyde; Myocardial Infarction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Vasoconstrictor Agents | 2021 |
Alarin moderated myocardial hypertrophy via inhibiting cyclic adenosine monophosphate/protein kinase A signaling pathway to attenuate autophagy.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cell Line; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Galanin-Like Peptide; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptors, Galanin; Signal Transduction | 2021 |